Publication | Closed Access

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Rapamycin Inhibitor Sar245409MedicineImmunologyImmune Checkpoint InhibitorAnti-cancer AgentCancer BiologyCell BiologyCancer Research